Revogene^® Carba C

Why Revogene Carba C?

Carbapenem-Resistant Enterobacterales (CRE) infections are hazardous to our patients and alarming for healthcare systems. The CDC has deemed CRE an urgent public health threat that requires immediate and aggressive action. ¹

Early identification and isolation of colonized or infected patients is key to limiting the spread of these organisms in healthcare settings and to help in better guidance of treatment.

1. https://www.cdc.gov/drugresistance/biggest_threats.html

• Efficient workflow - Sample to result in 3 easy steps

• Detects and differentiates the 5 known gene sequences (PC, NDM, VIM, OXA-48-like, IMP) associated with carbapene resistance.

• Platform for growth - Single analyte and multiplex testing capability

• Helps respond quickly to the threat of carbapenemase-producing organisms by providing results in 70 min.